Evommune Funding History

Since Evommune was founded in 2020, it has participated in 5 rounds of funding. In total Evommune has raised $268.0M. Evommune's last funding round was on Oct 2024 for a total of $115.0M.

Evommune Funding Rounds

Series C

Oct 2024

$115M

RA Capital Management, Sectoral Asset Management, B Capital, Marshall Wace, Longwood Fund, RTW Investments, NEXTBio Capital, FemHealth Ventures, Pivotal bioVenture Partners, EQT Life Sciences, Andera Partners, Amplitude Ventures, Symbiosis, Verition Fund Management

Series B

Jun 2023

$7.5M

Verition Fund Management

Series B

Apr 2023

$50M

Arix Bioscience, EQT, SymBiosis, Amplitude Ventures, Pivotal bioVenture Partners, Andera Partners

Series A

Sep 2021

$83M

Andera Partners, LSP, Pivotal bioVenture Partners

Seed

Nov 2020

$12.5M

Pivotal bioVenture Partners

Evommune Investors

RA Capital Management

Series C

Oct 2024

Sectoral Asset Management

Series C

Oct 2024

B Capital

Series C

Oct 2024

Marshall Wace

Series C

Oct 2024

Longwood Fund

Series C

Oct 2024

Evommune has 18 investors, including RA Capital Management, Sectoral Asset Management and B Capital. The latest investment occurred in Oct 2024.

Evommune Funding History

Since Evommune was founded in 2020, it has participated in 5 rounds of funding. In total Evommune has raised $268.0M. Evommune's last funding round was on Oct 2024 for a total of $115.0M.

Evommune Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

Total Funding: $268M

Evommune Investors

INVESTOR

ROUND

FUNDING DATE

Total Investors: 18